SELECTED IMPORTANT SAFETY INFORMATION

Some people who have taken medicine like ATRIPLA have developed build up of lactic acid in the blood, which can be a serious medical emergency that can lead to death.
Some people who have taken medicines like ATRIPLA have developed
serious liver problems, with liver enlargement and fat in the liver, which can lead to death.
If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, your hepatitis may suddenly
get worse. ATRIPLA is not approved for the treatment of HBV.

ATRIPLA: in English| en español

Search:

information for healthcare professionals

Please click here for more information about these warnings, including signs and symptoms, and other Important Safety Information.

Starting on ATRIPLA

It's the beginning of a fresh start now that you and your healthcare provider have chosen ATRIPLA, which is three meds in one pill daily.

ATRIPLA is a prescription medication used alone as a complete regimen, or with other anti-HIV-1 medicines, to treat HIV-1 infection in adults and children at least 12 years old who weigh at least 40 kg (88 lbs).

Deciding to begin HIV therapy requires a strong commitment. You must be ready to take your HIV medications exactly as your doctor directs. If you miss doses, HIV could become resistant to the medicines you are taking over time. This means your medicines could stop working for you.

What are some tips to help you remember to take your medications?

Do not change or stop your medicine without first talking to your healthcare provider.

ATRIPLA does not cure HIV-1 infection or AIDS and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections.

See your healthcare provider regularly while taking ATRIPLA.

Please click here for Important Safety Information, including information on buildup of lactic acid in the blood, serious liver problems, and sudden worsening of hepatitis B virus.

Please send me information and updates.

Find an HIV/AIDS Service Organization near you.

Distance to search:

Enter your ZIP code:

Site Map | Contact Us | Privacy Policy | Terms of Use | Unsubscribe

Click here for ATRIPLA Full Prescribing Information.

(c) 2012 Bristol-Myers Squibb Company.

ATRIPLA and ATRIPLA Peer Advocate Network are registered trademarks of Bristol-Myers Squibb & Gilead Sciences, LLC. SUSTIVA is a registered trademark of Bristol-Myers Squibb Company. COMPLERA, EMTRIVA, GILEAD, GSI, HEPSERA, TRUVADA, and VIREAD are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks referenced herein are the property of their respective owners.

Patient models are used on this Web site. The information on this site is intended for residents of the United States who are 18 years of age or older. The content of this site is protected under applicable copyright and trademarks law.

This site may contain, from time to time, information related to various health, medical and fitness conditions, and their treatment. Such information is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult a physician and/or a healthcare provider.

Your use of this information is subject to the terms and conditions of our Terms of Use and Privacy Policy.

697US12WA04601 07/12